Menu
/REGISTER
Montecito
Nixon Peabody
Chase
Bank of America
Loading...
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Patent ruling in favor of Amgen has shares skyrocketing

By   /   Friday, January 13th, 2017  /   Comments Off on Patent ruling in favor of Amgen has shares skyrocketing

    Print       Email
A ruling in a patent law case regarding an anti-cholesterol drug set the stage for a sharp run-up in the shares of Thousand Oaks biotech giant Amgen. Amgen had filed its patent infringement lawsuit against Sanofi and Regeneron in the U.S. District Court of Delaware in October 2014. The suit sought to block the development…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

UCSB New Venture Competition winners announced

Read More →